Universal Beteiligungs und Servicegesellschaft mbH Invests $1.43 Million in LifeStance Health Group, Inc. (NASDAQ:LFST)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired 214,932 shares of LifeStance Health Group, valued at approximately $1.43 million, raising its stake to about 0.06% of the company.
• Several institutional investors, including Vanguard Group and JPMorgan Chase & Co., have increased their holdings in LifeStance, highlighting growing interest as 85.50% of shares are held by hedge funds and institutional investors.
• LifeStance Health Group's stock is currently trading at $3.98, which is a significant drop of 5.9%, with analysts maintaining a consensus rating of "Moderate Buy" and a target price of $8.42.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 214,932 shares of the company's stock, valued at approximately $1,431,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.06% of LifeStance Health Group as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in LifeStance Health Group by 7.9% during the 4th quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock worth $78,781,000 after purchasing an additional 784,818 shares during the period. Jennison Associates LLC lifted its stake in shares of LifeStance Health Group by 2.1% during the 1st quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock worth $54,980,000 after purchasing an additional 168,856 shares during the period. Wellington Management Group LLP lifted its stake in shares of LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock worth $38,886,000 after purchasing an additional 445,796 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of LifeStance Health Group by 87.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after purchasing an additional 1,643,390 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of LifeStance Health Group by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock worth $25,546,000 after purchasing an additional 13,293 shares during the period. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Stock Up 0.6%

NASDAQ LFST traded up $0.03 during trading hours on Tuesday, hitting $3.93. The company had a trading volume of 727,685 shares, compared to its average volume of 1,846,185. LifeStance Health Group, Inc. has a fifty-two week low of $3.74 and a fifty-two week high of $8.61. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of -39.25 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. The firm's 50 day moving average is $4.93 and its 200 day moving average is $6.28.

Analysts Set New Price Targets

LFST has been the topic of several research reports. BTIG Research initiated coverage on LifeStance Health Group in a research report on Friday, July 25th. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp initiated coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price on the stock. Finally, UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a research report on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $8.42.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Ujjwal Ramtekkar sold 16,000 shares of the firm's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the sale, the insider directly owned 113,435 shares in the company, valued at $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is owned by corporate insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.